Ovulatory phase: estrogen peak supports collagen synthesis and visible glow.
Cycle protocol: weeks 1–2 (follicular/ovulatory) — focus on hydration and brightening; weeks 3–4 (luteal/premenstrual) — add salicylic acid 1–2% and reduce comedogenic occlusives.
If you're targeting acne, this research supports adding salicylic acid to your AM/PM routine.
If you're targeting acne, this research supports adding niacinamide to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Cycle-phase skin physiology: follicular phase characterized by low estradiol and decreased dermal hydration; ovulation peak estradiol drives collagen synthesis and visible luminosity; luteal progesterone elevation increases sebocyte activity and triggers premenstrual flare. Adjustable protocols outperform static regimens for cycling patients.
Skin physiology fluctuates predictably across the menstrual cycle. Follicular phase: low estrogen and progesterone produce drier, less elastic skin. Ovulatory phase: estrogen peak supports collagen synthesis and visible glow. Luteal phase: progesterone elevation increases sebum and triggers premenstrual acne. Cycle-aware skincare adjustments improve outcomes.
Original source →Acne vulgaris is common and has a substantial impact on patients' quality of life. Low adherence to acne treatments is a barrier to successful management. To examine the prevalence of adherence to oral and topical treatments for acne, factors associated with adherence and reasons for nonadherence.
Acne vulgaris is one of the most prevalent disorders affecting 9%-10% of the global population, representing as papules, pustules, and comedones, with a pathogenesis involving increased sebum production, C. acnes colonization, and inflammation. Conventional treatments like retinoids and antibiotics often cause side effects, thus diverting attention toward probiotics as an alternative therapy.
Emerging evidence suggests that the brain-gut-skin axis (BGSA) plays a critical role in the pathogenesis of inflammatory and disfiguring skin diseases. Conditions such as acne, atopic dermatitis, psoriasis, rosacea, vitiligo, and alopecia areata, once regarded as localized disorders driven mainly by cutaneous immune dysfunction, are now recognized as systemic conditions associated with neuroendocrine stress responses, gut microbial dysbiosis, and chronic low-grade inflammation. Mechanistic studies elucidate the intricate interorgan communication mediated by microbial metabolites (e.
This information is for educational purposes only and is not medical advice. Individual results vary. Consult a qualified dermatologist or healthcare professional for medical concerns. Full disclaimer →